Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension

NCT02178098 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Hypertension

Interventions

DRUG: ETC-1002
DRUG: Placebo

Sponsor

Esperion Therapeutics, Inc.

Collaborators

[object Object]